Amplifica
Amplifica Raises $26M Series B for Injectable Hair Growth Therapies
Amplifica announced $26M in Series B financing on August 12, 2026. Amplifica raised an oversubscribed $26 million Series B led by Tasso Partners to advance clinical development of its injectable hair-growth pipeline.
Round details
The financing includes backing from Tasso Partners, LLC, Eli Lilly and Company, Principals of Scopia Capital Management, LP. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $26M
How the company plans to use the capital
Amplifica said proceeds will be used to advance clinical development of its novel pipeline candidates, with its focus on clinical development activities within its injectable product pipeline.
Why this matters for GTM teams
The round was described as oversubscribed and included new and existing investors, and Amplifica describes itself as a clinical-stage company developing novel therapies for hair growth, with an injectable product pipeline.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Amplifica Series B announcement.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started